Related Experiment Video
Updated: Jul 30, 2026

13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Target antigens for prostate cancer immunotherapy
D C Saffran1, R E Reiter, A Jakobovits
1UroGenesys, Inc, Santa Monica, CA 90404, USA.
Cancer Metastasis Reviews
|June 16, 2000
Summary
Prostate cancer treatment advances include targeting specific antigens with immunotherapy. Research explores monoclonal antibodies and vaccines against advanced prostate cancer antigens for improved patient outcomes.
Area of Science:
- Oncology
- Immunology
- Biomarker Discovery
Background:
- Prostate-Specific Antigen (PSA) improved prostate cancer detection.
- Advanced metastatic prostate cancer remains incurable despite current treatments.
- Identifying novel therapeutic targets is crucial for advanced disease.
Purpose of the Study:
- To review target antigens in advanced prostate cancer.
- To discuss immunological therapies for prostate cancer.
- To evaluate the potential of these approaches for patient treatment.
Main Methods:
- Review of pre-clinical and clinical studies.
- Analysis of immunological therapies including monoclonal antibodies and cancer vaccines.
- Identification of antigens highly expressed in prostate cancer.
Main Results:
- Immunological therapies show promise in various cancers.
- Monoclonal antibody therapy is approved for other cancers and in trials for prostate cancer.
- Cancer vaccines targeting specific antigens are under investigation.
Conclusions:
- Target antigens and immunological approaches offer potential for treating advanced prostate cancer.
- Further research and clinical trials are needed to establish efficacy.
- Immunotherapy represents a promising frontier in prostate cancer treatment.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

